Particle.news

Download on the App Store

£1 Billion London Cancer Hub Planning Application Submitted

Aviva Capital Partners and Socius propose a transformative cancer research and treatment hub in Sutton, with a council decision expected by autumn 2025.

Image
Professor Kristian Helin, chief executive of the Institute of Cancer Research (ICR), expects the London Cancer Hub to attract the world’s leading biotech companies

Overview

  • The £1 billion masterplan aims to create a world-leading cancer research and treatment hub on a 12-acre site in Sutton, anchored by The Institute of Cancer Research and The Royal Marsden.
  • The proposed development includes one million square feet of state-of-the-art laboratories, offices, and incubator spaces for global pharmaceutical companies and start-ups.
  • If approved, construction is set to begin in 2026, with the first phase expected to be completed by 2028, creating 3,000 high-skilled jobs in life sciences and 340 annual construction roles.
  • Community-focused amenities include affordable housing for 220 key workers, restaurants, a creche, a pub for informal collaboration, and interim padel courts.
  • Public consultation with over 4,500 residents informed the plans, which promise £54 million in long-term social value through job creation, public amenities, and health improvements.